Zvi Farfel

5.7k total citations · 2 hit papers
88 papers, 4.3k citations indexed

About

Zvi Farfel is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zvi Farfel has authored 88 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 26 papers in Pulmonary and Respiratory Medicine and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zvi Farfel's work include Ion Transport and Channel Regulation (22 papers), Potassium and Related Disorders (12 papers) and Ion channel regulation and function (11 papers). Zvi Farfel is often cited by papers focused on Ion Transport and Channel Regulation (22 papers), Potassium and Related Disorders (12 papers) and Ion channel regulation and function (11 papers). Zvi Farfel collaborates with scholars based in Israel, United States and United Kingdom. Zvi Farfel's co-authors include Henry R. Bourne, Haim Mayan, David Julius, Kevin D. Lustig, Bruce R. Conklin, Meir Mouallem, Emanuel Hanski, Joseph Sack, Yoram Shechter and Joseph Meyerovitch and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Zvi Farfel

87 papers receiving 4.2k citations

Hit Papers

Human Hypertension Caused by Mutations in WNK Kinases 1993 2026 2004 2015 2001 1993 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zvi Farfel Israel 28 2.8k 662 651 619 484 88 4.3k
John A. Salmon United Kingdom 36 1.0k 0.4× 285 0.4× 689 1.1× 270 0.4× 371 0.8× 89 4.7k
Akihiro Sekine Japan 31 1.5k 0.6× 188 0.3× 136 0.2× 320 0.5× 800 1.7× 103 4.4k
Marvín I. Siegel United States 38 2.5k 0.9× 310 0.5× 293 0.5× 239 0.4× 402 0.8× 82 5.3k
Russell M. Medford United States 32 2.7k 1.0× 361 0.5× 389 0.6× 573 0.9× 200 0.4× 47 6.3k
K.C. Hayes United States 35 1.1k 0.4× 266 0.4× 1.4k 2.1× 356 0.6× 138 0.3× 104 4.4k
F. A. Kuehl United States 24 1.1k 0.4× 198 0.3× 308 0.5× 205 0.3× 523 1.1× 39 3.8k
Robert R. Gorman United States 37 1.2k 0.4× 275 0.4× 289 0.4× 344 0.6× 382 0.8× 90 4.8k
Pierre Borgeat Canada 40 1.5k 0.5× 387 0.6× 390 0.6× 363 0.6× 390 0.8× 108 5.1k
Stephen Jenkinson United States 30 1.2k 0.4× 729 1.1× 230 0.4× 198 0.3× 92 0.2× 98 3.2k
D J Hanahan United States 34 1.5k 0.5× 272 0.4× 469 0.7× 314 0.5× 183 0.4× 58 4.5k

Countries citing papers authored by Zvi Farfel

Since Specialization
Citations

This map shows the geographic impact of Zvi Farfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zvi Farfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zvi Farfel more than expected).

Fields of papers citing papers by Zvi Farfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zvi Farfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zvi Farfel. The network helps show where Zvi Farfel may publish in the future.

Co-authorship network of co-authors of Zvi Farfel

This figure shows the co-authorship network connecting the top 25 collaborators of Zvi Farfel. A scholar is included among the top collaborators of Zvi Farfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zvi Farfel. Zvi Farfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Habeck, Michael, Elmíra Tokhtaeva, Sean P. Ferris, et al.. (2016). Selective Assembly of Na,K-ATPase α2β2 Heterodimers in the Heart. Journal of Biological Chemistry. 291(44). 23159–23174. 33 indexed citations
3.
Mayan, Haim, Kira Oleinikov, Raphaël Halevy, et al.. (2015). Hypercalciuria in Familial Hyperkalemia and Hypertension with KLHL3 Mutations. ˜The œNephron journals/Nephron journals. 130(1). 59–65. 9 indexed citations
4.
Melnikov, Semyon, Haim Mayan, Shinichi Uchida, Eliezer J. Holtzman, & Zvi Farfel. (2011). Cyclosporine metabolic side effects: association with the WNK4 system. European Journal of Clinical Investigation. 41(10). 1113–1120. 49 indexed citations
5.
Sahar, Nadav, Ginette Schiby, Tima Davidson, et al.. (2009). Hairy cell leukemia presenting as multiple discrete hepatic lesions. World Journal of Gastroenterology. 15(35). 4453–4453. 7 indexed citations
6.
Mayan, Haim, et al.. (2002). Pseudohypoaldosteronism Type II: Marked Sensitivity to Thiazides, Hypercalciuria, Normomagnesemia, and Low Bone Mineral Density. The Journal of Clinical Endocrinology & Metabolism. 87(7). 3248–3254. 178 indexed citations
7.
Mayan, Haim, Osnat Gurevitz, & Zvi Farfel. (2002). Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman’s syndrome. Clinical Nephrology. 58(7). 73–76. 19 indexed citations
8.
Ben‐Horin, Shomron, Zvi Farfel, & Meir Mouallem. (2002). Gastroenteritis-Associated Hyperamylasemia. Archives of Internal Medicine. 162(6). 689–689. 11 indexed citations
9.
Wilson, Frederick H., Sandra Disse-Nicodème, Keith A. Choate, et al.. (2001). Human Hypertension Caused by Mutations in WNK Kinases. Science. 293(5532). 1107–1112. 1114 indexed citations breakdown →
10.
Kantor, Rami, et al.. (2000). Acquired Hemophilia Masked by Warfarin Therapy. The American Journal of the Medical Sciences. 319(3). 197–201. 7 indexed citations
11.
Kantor, Rami, et al.. (2000). Acquired Hemophilia Masked by Warfarin Therapy. The American Journal of the Medical Sciences. 319(3). 197–201. 4 indexed citations
12.
Mansfield, Traci A., David B. Simon, Zvi Farfel, et al.. (1997). Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nature Genetics. 16(2). 202–205. 157 indexed citations
13.
Harats, Dror, Rachel Pauzner, Deborah Elstein, et al.. (1997). Pulmonary Hypertension in Two Patients with Type I Gaucher Disease while on Alglucerase Therapy. Acta Haematologica. 98(1). 47–50. 26 indexed citations
14.
Shapira, Hagit, Meir Mouallem, M. Shapiro, Yosef Weisman, & Zvi Farfel. (1996). Pseudohypoparathyroidism type Ia: two new heterozygous frameshift mutations in exons 5 and 10 of the Gs? gene. Human Genetics. 97(1). 73–5. 31 indexed citations
15.
Conklin, Bruce R., Zvi Farfel, Kevin D. Lustig, David Julius, & Henry R. Bourne. (1993). Substitution of three amino acids switches receptor specificity of Gqα to that of Giα. Nature. 363(6426). 274–276. 626 indexed citations breakdown →
16.
Mayan, Haim, et al.. (1992). EDTA-Induced Pseudothrombocytopenia. Southern Medical Journal. 85(2). 213–214. 4 indexed citations
17.
Farfel, Zvi, et al.. (1990). Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination. Journal of Medical Microbiology. 32(3). 173–177. 29 indexed citations
18.
Leor, Jonathan, et al.. (1988). Amiodarone and β-adrenergic blockers: An interaction with metoprolol but not with atenolol. American Heart Journal. 116(1). 206–207. 15 indexed citations
19.
Almog, Shlomo, U. Martinowitz, Hillel Halkin, H Bank, & Zvi Farfel. (1988). Complex Interaction of Rifampin and Warfarin. Southern Medical Journal. 81(10). 1304–1306. 19 indexed citations
20.
Schwartz, Eli, Eitan Friedman, Meir Mouallem, & Zvi Farfel. (1988). Sinus arrest associated with clonidine therapy. Clinical Cardiology. 11(1). 53–54. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026